Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial.

Wunderink, Richard G; Laterre, Pierre-François; Francois, Bruno; Perrotin, Dominique; Artigas, Antonio; Vidal, Luis Otero; Lobo, Suzana M; Juan, Jorge San; Hwang, Sung Chul; Dugernier, Thierry; LaRosa, Steven; Wittebole, Xavier; Dhainaut, Jean-Francois; Doig, Christopher; Mendelson, Meryl H; Zwingelstein, Christian; Su, Guoqin; Opal, Steven

Wunderink, Richard G; Laterre, Pierre-François; Francois, Bruno; Perrotin, Dominique; Artigas, Antonio; Vidal, Luis Otero; Lobo, Suzana M; Juan, Jorge San; Hwang, Sung Chul; Dugernier, Thierry; LaRosa, Steven; Wittebole, Xavier; Dhainaut, Jean-Francois; Doig, Christopher; Mendelson, Meryl H; Zwingelstein, Christian; Su, Guoqin; Opal, Steven.

Affiliation

Wunderink RG; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. r-wunderink@northwestern.edu

Am J Respir Crit Care Med ; 183(11): 1561-8, 2011 Jun 01.

Article in En | MEDLINE | ID: mdl-21297074

Subject(s)

Anti-Bacterial Agents/therapeutic use; Pneumonia/drug therapy; Proteins/therapeutic use; Adult; Aged; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Proteins/administration & dosage; Severity of Illness Index; Survival Analysis; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Proteins / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google